279 related articles for article (PubMed ID: 22936651)
1. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study.
Collins B; MacKenzie J; Tasca GA; Scherling C; Smith A
Psychooncology; 2013 Jul; 22(7):1517-27. PubMed ID: 22936651
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
3. Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls.
Ando-Tanabe N; Iwamitsu Y; Kuranami M; Okazaki S; Yasuda H; Nakatani Y; Yamamoto K; Watanabe M; Miyaoka H
Breast Cancer; 2014 Jul; 21(4):453-62. PubMed ID: 22976288
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
5. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
Psychooncology; 2009 Feb; 18(2):134-43. PubMed ID: 18551510
[TBL] [Abstract][Full Text] [Related]
6. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
Jung MS; Cimprich B
Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
[TBL] [Abstract][Full Text] [Related]
7. The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.
Shilling V; Jenkins V; Morris R; Deutsch G; Bloomfield D
Breast; 2005 Apr; 14(2):142-50. PubMed ID: 15767184
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
Quesnel C; Savard J; Ivers H
Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
[TBL] [Abstract][Full Text] [Related]
9. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy.
Ahles TA; Saykin AJ; Noll WW; Furstenberg CT; Guerin S; Cole B; Mott LA
Psychooncology; 2003 Sep; 12(6):612-9. PubMed ID: 12923801
[TBL] [Abstract][Full Text] [Related]
10. Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.
Prokasheva S; Faran Y; Cwikel J; Geffen DB
J Psychosoc Oncol; 2011; 29(5):499-514. PubMed ID: 21882931
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.
Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM
J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578
[TBL] [Abstract][Full Text] [Related]
12. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
Jenkins V; Shilling V; Fallowfield L; Howell A; Hutton S
Psychooncology; 2004 Jan; 13(1):61-6. PubMed ID: 14745746
[TBL] [Abstract][Full Text] [Related]
13. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
[TBL] [Abstract][Full Text] [Related]
14. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study.
Hermelink K; Untch M; Lux MP; Kreienberg R; Beck T; Bauerfeind I; Münzel K
Cancer; 2007 May; 109(9):1905-13. PubMed ID: 17351951
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
Hermelink K; Henschel V; Untch M; Bauerfeind I; Lux MP; Munzel K
Cancer; 2008 Nov; 113(9):2431-9. PubMed ID: 18823033
[TBL] [Abstract][Full Text] [Related]
16. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
[TBL] [Abstract][Full Text] [Related]
17. Effects of adjuvant treatment on cognitive function in women with early breast cancer.
Hedayati E; Alinaghizadeh H; Schedin A; Nyman H; Albertsson M
Eur J Oncol Nurs; 2012 Jul; 16(3):315-22. PubMed ID: 21908235
[TBL] [Abstract][Full Text] [Related]
18. 'Chemobrain' in breast carcinoma?: a prologue.
Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
[TBL] [Abstract][Full Text] [Related]
19. No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy.
Mehlsen M; Pedersen AD; Jensen AB; Zachariae R
Psychooncology; 2009 Mar; 18(3):248-57. PubMed ID: 18756583
[TBL] [Abstract][Full Text] [Related]
20. Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy.
Collins B; Mackenzie J; Tasca GA; Scherling C; Smith A
J Int Neuropsychol Soc; 2014 Apr; 20(4):370-9. PubMed ID: 24229809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]